DUBLIN--(BUSINESS WIRE)--The "Myocardial Ischemia - Pipeline Review, H2 2017" report has been added to Research and Markets' offering. Myocardial Ischemia - Pipeline Review, H2 2017, provides ...

Key points A 56-year-old woman presented to the emergency department with a 2-day history of central chest pain and dyspnea. Her medical history included having had a myocardial infarction (MI) with n ...

Acute myocardial ischemia occurs when blood flow is restricted in the heart. This usually leads to cardiovascular issues, but treatments have advanced quite far. However, one thing that still plagues ...

Ischemic heart disease is the leading cause of death globally, causing approximately 9 million deaths annually. Currently, reperfusion therapy (such as thrombolysis or interventional procedures) is ...

In patients with ST-segment elevation myocardial infarction (STEMI) with multivessel coronary artery disease, the time at which complete revascularization of nonculprit lesions should be performed ...

The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction (LVEF) is unclear. We conducted a meta-analysis at the individual-patient level ...

Heart attacks, or acute myocardial infarction (MI), are one of the leading causes of death worldwide. The newly released Canadian Cardiovascular Society Classification of Acute Myocardial Infarction ...

Please provide your email address to receive an email when new articles are posted on . Among patients with HF with preserved ejection fraction, those with ischemic heart disease had increased risk ...

SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ...